Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,849,680 papers from all fields of science
Search
Sign In
Create Free Account
CCL28 wt Allele
Known as:
SCYA28
, CCK1
, MEC
Expand
Human CCL28 wild-type allele is located in the vicinity of 5p12 and is approximately 36 kb in length. This allele, which encodes C-C motif chemokine…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
C-C Motif Chemokine 28
Chemotaxis
Cytokine Receptor Binding
Cytokine Signaling
Expand
Broader (1)
CCL28 gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Brain-gut axis in the modulation of pancreatic enzyme secretion.
J. Jaworek
,
K. Nawrot-Porąbka
,
A. Leja-Szpak
,
S. Konturek
Journal of Physiology and Pharmacology
2010
Corpus ID: 20298803
Pancreatic enzyme secretion is controlled by complex of neurohormonal mechanisms, activated by nutrients. Food components in the…
Expand
2007
2007
Endogenous cholecystokinin reduces food intake and increases Fos-like immunoreactivity in the dorsal vagal complex but not in the myenteric plexus by CCK1 receptor in the adult rat.
Cherese N. Sullivan
,
S. J. Raboin
,
+4 authors
A. Sayegh
American Journal of Physiology. Regulatory…
2007
Corpus ID: 2444166
We hypothesized that endogenous CCK reduces food intake by activating the dorsal vagal complex (DVC) and the myenteric neurons of…
Expand
2007
2007
Optimization of 1,3,4-benzotriazepine-based CCK(2) antagonists to obtain potent, orally active inhibitors of gastrin-mediated gastric acid secretion.
I. M. Mcdonald
,
J. Black
,
+18 authors
Wei Xun
Journal of Medicinal Chemistry
2007
Corpus ID: 30908988
Starting from a novel, achiral 1,3,4-benzotriazepine-based CCK2 receptor antagonist, a process of optimization has afforded…
Expand
2006
2006
Weight gain and maternal behavior in CCK1 deficient rats
M. Schroeder
,
O. Zagoory-Sharon
,
Y. Lavi-Avnon
,
T. Moran
,
A. Weller
Physiology and Behavior
2006
Corpus ID: 1717882
Review
2006
Review
2006
CCK1 Antagonists: Are They Ready for Clinical Use?
S. Peter
,
M. D'Amato
,
C. Beglinger
Digestive Diseases
2006
Corpus ID: 24378430
Cholecystokinin (CCK) is a peptide hormone which is found both in the gastrointestinal tract throughout the human small intestine…
Expand
2005
2005
Cholecystokinin-8 increases Fos-like immunoreactivity in the brainstem and myenteric neurons of rats through CCK1 receptors
S. Gulley
,
S. K. Sharma
,
T. Moran
,
A. Sayegh
Peptides
2005
Corpus ID: 38064540
Review
2002
Review
2002
Dexloxiglumide Rotta Research Lab.
G. Varga
Current opinion in investigational drugs
2002
Corpus ID: 23195857
Dexloxiglumide, the (R)-isomer of loxiglumide, is a selective and highly potent CCK1 receptor antagonist. It is twice as potent…
Expand
Review
2001
Review
2001
CCK-ergic mechanisms in sensory systems.
T. Hökfelt
,
K. Holmberg
,
T. Shi
,
C. Broberger
Scandinavian journal of clinical and laboratory…
2001
Corpus ID: 32623431
The histochemical analysis of cholecystokinin (CCK) systems in sensory systems has revealed involvement of CCK-ergic mechanisms…
Expand
Review
2000
Review
2000
Involvement of cholecystokinin within craving for cocaine: role of cholecystokinin receptor ligands
F. Crespi
,
M. Corsi
,
A. Reggiani
,
E. Ratti
,
G. Gaviraghi
Expert Opinion on Investigational Drugs
2000
Corpus ID: 30119549
In the brain, cholecystokinin (CCK) has been described to act as a central neurotransmitter or neuromodulator involved in…
Expand
1999
1999
Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells
E. Lindström
,
M. Björkqvist
,
R. Håkanson
British Journal of Pharmacology
1999
Corpus ID: 45536591
Gastrin stimulates rat stomach ECL cells to secrete histamine and pacreastatin, a chromogranin A (CGA)‐derived peptide. The…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE